환자 정보 전단
Date revised: 15.02.2017
Print date: 26.05.17
2 / GB- 800089-004-02
Version: 2 / GB
Replaces Version: 1 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEOSAN CARE
Page 1(9)
SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1. PRODUCT IDENTIFIER
neosan Care
1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES
ADVISED AGAINST
USE OF THE SUBSTANCE/PREPARATION
Cosmetics, personal care products
1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
ADDRESS:
Chemische Fabrik Dr. Weigert GmbH & Co. KG
Mühlenhagen 85
D-20539 Hamburg
Telephone no.
+49 40 789 60 0
Fax no.
+49 40 789 60 120
www.drweigert.com
E-MAIL ADDRESS OF PERSON RESPONSIBLE FOR THIS SDS:
sida@drweigert.de
1.4. EMERGENCY TELEPHONE NUMBER
GBK/ Infotrac: (USA domestic) 1 800 535 5053 or international +1 352
323 3500
SECTION 2: HAZARDS IDENTIFICATION
2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
CLASSIFICATION (REGULATION (EC) NO. 1272/2008)
Classification (Regulation (EC) No. 1272/2008)
Aquatic Chronic 3
H412
2.2. LABEL ELEMENTS
LABELLING ACCORDING TO REGULATION (EC) NO 1272/2008
HAZARD STATEMENTS
H412
Harmful to aquatic life with long lasting effects.
PRECAUTIONARY STATEMENTS
P273
Avoid release to the environment.
Dispose only when container is empty and closed. For disposal of
product
residues, refer to Safety Data Sheet.
2.3. OTHER HAZARDS
No special hazards have to be mentioned.
SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS
3.2. MIXTURES
HAZARDOUS INGREDIENTS
ALKYLDIMETHYLAMINE OXIDE
CAS No.
308062-28-4
Registration no.
01-2119490061-47
Concentration
<
1
%
Date revised: 15.02.2017
Print date: 26.05.17
2 / GB- 800089-004-02
Version: 2 / GB
Replaces Version: 1 /
GB
SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO
1907/2006 NEOSAN CARE
Page 2(9)
Classification (Regulation (EC) No. 1272/2008)
Acute Tox. 4
H302
Skin Irrit. 2
H315
Eye Dam. 1
H318
Aquatic Acute 1
H400
Aquatic Chronic 2
H411
PROPAN-2-OL
CAS No.
67-63-0
EINECS no.
200-661-7
Registration no.
01-2119457558-25
Con
전체 문서 읽기
환자 정보 전단 